Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: A Study of TG103 Injection in Type 2 Diabetes Subjects [Phase 2]
Phase 2 clinical trial update for TG103 Injection in adults with Type 2 Diabetes Mellitus.
-
FDA approval · 2022-06-10FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Trulicity (dulaglutide) from Eli Lilly and Company.
-
FDA approval · 2022-06-10FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Soliqua 100/33 (insulin glargine and lixisenatide) submitted by Sanofi-Aventis U.S. LLC. Thi…
-
FDA approval · 2022-06-10FDA Approved: XULTOPHY 100/3.6 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application to add XULTOPHY 100/3.6, a fixed-ratio combination of insulin degludec and liraglutide, for adul…
-
FDA approval · 2022-06-10FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for the oral formulation of OZEMPIC (semaglutide) by Novo Nordisk.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-06-10FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2022-06-09FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Solco Healthcare US, LLC.)
FDA approved the Original Application for Metformin Hydrochloride from Solco Healthcare US, LLC., enabling a generic metformin hydrochloride…
-
FDA approval · 2022-06-07FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-Aventis U.S. LLC, authorizing changes to the …
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: KurCoSmart Effects on People With Type 2 DM [Phase 1, Phase 2]
Clinical trial update for KurCoSmart in adults with type 2 diabetes and insulin resistance; phase 1 and phase 2 studies are ongoing with unk…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Modified Foot Exercise to Improve Sensitivity and Perfussion on Type 2 Diabetes Patients [Phase 1, Phase 2]
A clinical trial update on a modified foot exercise aimed at improving sensitivity and perfusion in patients with Type 2 diabetes, currently…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Pilot Study to Assess the Effects of Hepatic Ultrasound Insonification on Subjects With T2DM [NA]
A completed pilot study evaluating hepatic ultrasound insonification effects in subjects with type 2 diabetes; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients [Phase 3]
Phase 3 trial evaluating YYC405 for efficacy and safety in Type 2 Diabetes is ongoing with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin [Phase 3]
Phase 3 trial update on dapagliflozin for Asian adults with type 2 diabetes inadequately controlled on metformin/saxagliptin; study terminat…
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM) [Phase 4]
Phase 4 trial assessing the effects of insulin treatment on postprandial platelet activation in patients with type 2 diabetes mellitus and p…
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients [Phase 4]
Phase 4 trial evaluating antiplatelet effects of different aspirin dosages in patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy [Phase 2]
Phase 2 clinical trial update for SB-509 in diabetic neuropathy has completed enrollment and status is completed.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes [Phase 4]
Phase 4 clinical trial comparing glimepiride versus sitagliptin as add-on therapy to metformin in severe insulin-deficient type 2 diabetes; …
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial update evaluating different doses of SY-004 in patients with Type 2 Diabetes Mellitus completed.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Testosterone for Peripheral Vascular Disease [Phase 4]
Phase 4 trial update on testosterone for peripheral vascular disease, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On [Phase 4]
Phase 4 clinical trial evaluating mineralocorticoid receptor antagonism as an add-on in atherosclerosis has been terminated with results pos…
-
FDA approval · 2022-05-13FDA Approved: MOUNJARO — Original Application (Eli Lilly and Company)
FDA approved MOUNJARO (tirzepatide) from Eli Lilly under Original Application NDA 215866 for adults with type 2 diabetes mellitus to improve…
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Peanuts and Glycemic Control [Phase 2]
Phase 2 clinical trial evaluating peanut intake for glycemic control in type 2 diabetes with cardiovascular disease showed completed results…
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease [Phase 2]
Phase 2 dose-finding study of colchicine in Type 2 diabetes patients with coronary artery disease completed.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus [Phase 2]
Phase 2 double-blind trial evaluating two doses of an investigational product for 16 weeks in adults with non-alcoholic steatohepatitis and …
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects [Phase 1, Phase 2]
Phase 1/2 trial evaluating allogeneic mesenchymal stem cell infusion therapy for endothelial dysfunction in adults with type 2 diabetes; stu…